Corsera Health

Boston, United States

Corsera Health develops preventive RNA interference medicines that reduces cardiovascular disease risk before long-term damage occurs.

$80.0M raised

Jan 2026

Series A

Biotechnology Emergency Medicine Medical

Top Investors

Forbion Capital PartnersPopulation Health PartnersJohn Maraganore

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Corsera Health

How much funding has Corsera Health raised?

Corsera Health has raised $80.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.

Who are Corsera Health's investors?

Corsera Health's investors include Forbion Capital Partners, Population Health Partners, John Maraganore.

Where is Corsera Health headquartered?

Corsera Health is headquartered in Boston, United States.

What does Corsera Health do?

Corsera Health develops preventive RNA interference medicines that reduces cardiovascular disease risk before long-term damage occurs.

What stage is Corsera Health at?

Corsera Health is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 7, 2026.

MLA

"Corsera Health — Funding & Investors." VCBacked, January 7, 2026, https://www.vcbacked.co/company/corsera-health. Accessed June 3, 2026.

APA

VCBacked. (2026). Corsera Health — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/corsera-health

Wikipedia (cite web)

{{cite web |title=Corsera Health — Funding & Investors |url=https://www.vcbacked.co/company/corsera-health |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 7, 2026.

Similar Companies in Biotechnology